<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-TNRC-11001348</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2011-06-03</date_registration>
      <primary_sponsor>Institute of Hematology of Union Hospital</primary_sponsor>
      <public_title>Relapse leukemia treatment  following  allogeneic HSCT by CIK</public_title>
      <acronym />
      <scientific_title>Relapse leukemia treatment following allogeneic HSCT by recipient derived donor origin CIK</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2011-06-01</date_enrolment>
      <type_enrolment />
      <target_size>Group A:15;Group B:20;Group C:20;</target_size>
      <recruitment_status>Completed</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=8191</url>
      <study_type>Observational study</study_type>
      <study_design>Non randomized control</study_design>
      <phase>I+II (Phase I+Phase II)</phase>
      <hc_freetext>Actue leukemia</hc_freetext>
      <i_freetext>Group A:Chemothrapy+DLI;Group B:Chemothrapy+CIK;Group C:Chemotherapy;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Yong You</firstname>
        <middlename />
        <lastname />
        <address>1277 Jiefang Road, Wuhan, China</address>
        <city />
        <country1 />
        <zip>430022</zip>
        <telephone>+86 13907146261</telephone>
        <email>youunion@126.com</email>
        <affiliation>Union Hospital of Wuhan</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yong You</firstname>
        <middlename />
        <lastname />
        <address>1277 Jiefang Road, Wuhan, China</address>
        <city />
        <country1 />
        <zip>430022</zip>
        <telephone>+86 13907146261</telephone>
        <email>youunion@126.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. the relapsed leukemia is confirmed by cytomytric and cytogenetic tests as recipient origin;
2. Patients must have adequate renal function with a serum creatinine of &lt; 2 mg/dl or creatinine clearance &gt; 50 ml/min;
3. Patients must have adequate liver function with a total bilirubin &lt; 2 mg/dl or transaminases &lt; 3 times the upper limit of normal;
4. HIV negative;
5. Patients must sign informed consent prior to initiation of any study-related treatments;
6. The mononuclears in the peripheral blood of patients should nearly be donor type.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>55</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. LVEF &lt; 45%;
2. Pulmonary diffusion capacity &lt; 50% predicted; 
3. Total bilirubin &gt; 2 mg/dl; 
4. Creatinine &gt; 2 mg/dl; 
5. Pregnancy;
6. Patients positive for HIV; 
7. Patients have the active ,uncontrolled infection;
8. The mononuclears in peripheral blood are not totally donor type.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>leukemia free survival;GVHD;over all survival;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Institute of Hematology of Union Hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Not approved</status>
        <approval_date>2013-08-26</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>